Form 4: SVP at Soleno Therapeutics Sells Shares to Cover Tax Obligations

Kristen Yen, Senior Vice President at Soleno Therapeutics, sold shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• Kristen Yen, a Senior Vice President at Soleno Therapeutics, sold shares of the company's common stock on July 1, 2024.
• The sales were executed in two transactions to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
• In the first transaction, 473 shares were sold at a weighted average price of $41.2217, with individual prices ranging from $40.39 to $41.38.
• In the second transaction, 1,697 shares were sold at a weighted average price of $41.6254, with individual prices ranging from $41.39 to $42.08.
• Following these transactions, Yen directly owns 21,252 shares of Soleno Therapeutics common stock, some of which are RSUs representing a contingent right to receive one share of common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction (selling shares to cover taxes on vested RSUs), so the sentiment is neutral.

Industry Context

Form 4 filings are a routine part of the stock market, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking to understand management's perspective on the company's stock.

Stakeholder Impact

• The sale of shares by an officer could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates